FundedIQ
Biotechnology

Dancann Pharma: Funding, Investors & Team (Sep 2026)

Streaks AI is a leading developer of conversational AI platforms, pioneering innovative solutions for seamless and interactive communication. Specialising in creating advanced conversational interfaces, Streaks AI leverages artificial intelligence to enhance user experiences across various industries.

www.dancann.com LinkedIn Ansager, Denmark 11-50 employees
Biotechnology Manufacturing Medical Pharmaceutical Therapeutics B2B
Total raised
$1.3M
Rounds
2
Latest
Undisclosed round
Jul 2025

Dancann Pharma has raised $1.3M across 2 funding rounds on record, the most recent an undisclosed round of $310k announced in Jul 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Dancann Pharma Company Profile and Key Stats

Total funding raised
$1.3M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$310k in Jul 2025
Employees
11-50
reported band
Headquarters
Ansager, Denmark

Latest funding round on record: Jul 2025.

Dancann Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
$310k
Undisclosed round
$1.0M

Dancann Pharma raised $1.0M in an undisclosed round announced in Jun 2024.

1.1 years later, an undisclosed round of $310k was announced in Jul 2025.

Dancann Pharma Founders and Leadership Team

Name
Role
Contact
Jeppe Krog Rasmussen
Founder
Jeppe Rasmussen
Founder

No contact details are on record for this team yet.

Dancann Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
371
$3.8M

Dancann Pharma's latest round of $310k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Dancann Pharma in Biotechnology and Ansager

Companies Similar to Dancann Pharma

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…

Undisclosed round $3.1M

Alcolase is a Danish life science start-up that specializes in alcohol flushing.

Seed $1.7M

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…

Series C $75.0M

ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution

Angel $240k

Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…

Seed $1.5M

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…

Seed $1.5M

Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…

Undisclosed round $275M

Pioneering new sustainable bio-based ingredients

Series A $5.9M

Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…

Undisclosed round $1.0M

EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…

Undisclosed round $7.1M

Fida Biosystems is a technology that provides the detection and characterization of proteins and…

Series A $5.9M

Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…

Undisclosed round $8.1M

Dancann Pharma Funding FAQs

What does Dancann Pharma do?

Streaks AI is a leading developer of conversational AI platforms, pioneering innovative solutions for seamless and interactive communication. Specialising in creating advanced conversational interfaces, Streaks AI leverages artificial intelligence to enhance user experiences across various industries.

How much funding has Dancann Pharma raised?

Dancann Pharma has raised $1.3M across 2 rounds on record. The most recent is an undisclosed round of $310k announced in Jul 2025.

When did Dancann Pharma last raise funding?

Dancann Pharma's most recent funding round on record is an undisclosed round of $310k, announced in Jul 2025.

Who founded Dancann Pharma?

FundedIQ lists Jeppe Krog Rasmussen (Founder), Jeppe Rasmussen (Founder) at Dancann Pharma.

Where is Dancann Pharma headquartered?

Dancann Pharma is based in Ansager, Syddanmark, Denmark.

How many employees does Dancann Pharma have?

Dancann Pharma is in the 11-50 employee band.

How does Dancann Pharma's funding compare to other Biotechnology startups?

Dancann Pharma's latest round of $310k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Dancann Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dancann Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.